Precision pharmacotherapy of atomoxetine in children with ADHD: how to ensure the right dose for the right person?
Frontiers in Pharmacology · 29.10.2024 · 15
DOI: 10.3389/fphar.2024.1484512 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.10.2024. Verfasst von Hong-Li Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Research Center, Department of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Non-stimulant atomoxetine is recognized in various current clinical guidelines as an important alternative to stimulants for the pharmacological treatment of attention deficit/hyperactivity disorder (ADHD) in children. While its efficacy and tolerability for core symptoms are established, there is considerable inter-individual variability in response and exposure, highlighting the need for personalized dosing. In this review, we evaluated existing studies and summarized comprehensive evidence supporting the clinical implementation of therapeutic drug monitoring (TDM) and personalized dosing of atomoxetine, organized around a series of logically structured questions. Although there are notable gaps in achieving personalized dosing across multiple critical elements, the available evidence is helpful to endorse personalized dose adjustments based on TDM and CYP2D6 genotyping “whenever possible.” We advocate for ongoing improvement and enhancement in clinical practice. Future advancements will rely on a deeper understanding of ADHD, facilitating more precise diagnoses and personalized treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmaceutical Sciences Research Center, Department of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, China.
- Department of Children Healthcare, Children's Hospital of Nanjing Medical University, Nanjing, China.
Zitieren
APA
Guo, H. L., Huang, J., Wang, J., Fan, L., Li, Y., Wu, D. D., Liu, Q. Q., & Chen, F. (2024). Precision pharmacotherapy of atomoxetine in children with ADHD: how to ensure the right dose for the right person?. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1484512
Vancouver
Guo HL, Huang J, Wang J, Fan L, Li Y, Wu DD, et al. Precision pharmacotherapy of atomoxetine in children with ADHD: how to ensure the right dose for the right person?. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1484512
BibTeX
@article{Guo2024,
author = {Guo, Hong-Li and Huang, Jian and Wang, Jie and Fan, Lin and Li, Yue and Wu, Dan-Dan and Liu, Qian-Qi and Chen, Feng},
title = {Precision pharmacotherapy of atomoxetine in children with ADHD: how to ensure the right dose for the right person?},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1484512}
}
EUVIMED